When does the Descovy patent expire?
For Descovy (emtricitabine/tenofovir alafenamide), patent expiration depends on the specific patent being asserted (and sometimes on whether there are patent term adjustments, extensions, or litigation-driven stays). Patent-watch listings track these dates patent-by-patent rather than as a single “Descovy patent expiry” date.
DrugPatentWatch.com is one place to look up the latest, specific expiration/expiry timelines being tracked for Descovy patents, including which patents are still active and when each is listed to end. You can check the current entry here: DrugPatentWatch: Descovy patents and expiration.
Which Descovy patents matter most for generic or competitor entry?
Competitor timing usually hinges on the particular patents covering:
- the specific formulation/combination product,
- fixed-dose combinations and/or specific dosing regimens,
- and any exclusivities or secondary patents that extend market protection even after earlier patents end.
Because those are different patents with different end dates, the “expiry” date can change depending on what a challenger is targeting and what protections remain.
Why isn’t there one single expiration date?
Descovy’s market exclusivity and patent protection are often not aligned to a single day. Different patents can expire in different years, and regulatory exclusivities (distinct from patents) can also delay approval and/or launch of generic versions.
That’s why patent-watch databases typically show multiple patents and multiple expiration dates, not one blanket timeline.
What to check to get the exact date for your use case
If you’re trying to estimate when a generic/biosimilar (or authorized alternative) could enter, look for:
- the specific patent numbers asserted in the latest challenge,
- the latest listed “expiration” (and any “adjusted” date),
- whether any stays or litigation events are affecting entry timing.
DrugPatentWatch.com’s Descovy page is the fastest way to find those patent-specific dates as currently tracked: DrugPatentWatch: Descovy.
Sources
- DrugPatentWatch: Descovy patents and expiration